Cancer Biomarker Discovery and Therapeutic Targeting | HBKU
Apply Now
Hamad Bin Khalifa University

Cancer Biomarker Discovery and Therapeutic Targeting

Led by Dr. Nehad Alajez

Cancer Biomarker and Therapeutic Targeting

Led by Dr. Nehad Alajez

  • Identification of the microRNA/lncRNA molecular signature associated with pathological complete response to neoadjuvant chemotherapy in Triple Negative (TN) breast cancer (BC).
  • Circulating microRNAs and lncRNAs as novel biomarkers for early breast and colorectal cancer detection.
  • Cell-based functional high-throughput small molecule library screens to identify novel therapeutic agents for breast and colorectal cancer.

Scientists

  • Dr. Nehad Alajez

    Dr. Nehad Alajez Principal Investigator